Epilepsy Surgery and Spatial Memory Study

This study is looking into how memory for places and scenes works in people with focal epilepsy (seizures starting in one area of the brain) and temporal lobe epilepsy (a type of focal epilepsy). We know that standard memory tests don't always capture the memory problems people with epilepsy experience, especially with remembering places. This research uses a "Virtual Tour Recognition Memory Task" where you'll watch short video clips of virtual scenes and then be tested on your memory for them. Some participants will also have "Intracranial EEG Recording with Research Electrodes" (special brain recordings during surgery) or "MRI Neuroimaging and Neuropsychological Assessment" (brain scans and memory tests). The study aims to understand which parts of the brain are important for remembering scenes and how this relates to epilepsy. We're looking for people aged 18 to 55 with focal or temporal lobe epilepsy, or healthy adults, who can speak English and have an IQ of 70 or higher. The study is currently unclear on its recruitment status.

Study design
This is an interventional study planning to enroll 620 participants. It uses different approaches, including studying surgical patients, healthy adults, and patients undergoing brain recordings.
What's involved
You would participate in a "Virtual Tour Recognition Memory Task." Depending on the study aim, you might also have brain imaging (MRI) and extensive neuropsychological assessments before and after surgery, or intracranial EEG recording during hospitalization.
Compensation
Not stated in the trial record.
Follow-up
Testing is scheduled within eight weeks of enrollment. For some participants, repeat testing will occur at six and 12 months after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07580183

Spatial Scene Recognition Memory in Epilepsy Surgery

Recruiting
NAAges 18–55InterventionalBasic science
University of California, Davis
~620 participants
Updated 2026-05-12 on ClinicalTrials.gov
What's tested:Virtual Tour Recognition Memory TaskIntracranial EEG Recording with Research Electrodes (Aim III only)MRI Neuroimaging and Neuropsychological Assessment (Aim I)

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Scene familiarity discrimination accuracy
Measured over From enrollment until the end of eight weeks, during which time testing is scheduled (Aim II), or during the hospitalization for invasive EEG studies (Aim III). Participants in Aim I can undergo repeat testing (six months, one year, etc.)
+4 more outcomes measured
Focal Epilepsy
Temporal Lobe Epilepsy
Medically Refractory Epilepsy
Memory Disorders
Epilepsy Comorbidities
Epilepsy Intractable
Epilepsy Surgery
Epilepsy, Temporal Lobe
Memory Deficits
Memory Disorder, Spatial
Memory Dysfunction
Spatial Perception
2 sites across 2 states
California1
Georgia1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years or older
For Aims I and III: Diagnosis of focal epilepsy or temporal lobe lesion; patients undergoing evaluation for or having undergone epilepsy surgery
For Aim II: Healthy adult participants
Full-Scale IQ ≥ 70
English proficiency sufficient to understand and complete the task
For Aim I: Enrolled in or eligible for Emory University epilepsy surgery research registry
For Aim III: Undergoing clinically indicated stereoelectroencephalography (SEEG) at UC Davis Medical Center
Able to provide informed consent (or for Aim I retrospective component, prior consent in Emory registry)

Exclusion

Full-Scale IQ \< 70
Inability to provide informed consent
For Aim III: Age \> 55 years
For Aim II: History of neurological or psychiatric disorder (as applicable per study protocol)
  • Scene familiarity discrimination accuracyFrom enrollment until the end of eight weeks, during which time testing is scheduled (Aim II), or during the hospitalization for invasive EEG studies (Aim III). Participants in Aim I can undergo repeat testing (six months, one year, etc.)

    Rate of correct familiarity judgments for spatially similar test scenes versus novel scenes (recognition without identification/RWI effect), measured as the proportion of "familiar" responses to configurally matched scenes minus false alarm rate to novel scenes.

  • Scene recall accuracyFrom enrollment until the end of eight weeks, during which time testing is scheduled (Aim II), or during the hospitalization for invasive EEG studies (Aim III). Participants in Aim I can undergo repeat testing (six months, one year, etc.)

    Proportion of test scenes for which participants correctly recall the name or identifying details of the corresponding study scene (verified recall), separately for identical repeat scenes and configurally similar scenes.

  • Lesion-symptom correlation for familiarity and recall (Aim I)Testing is scheduled within eight weeks of enrollment for all patients, with repeat testing at six and 12 months after surgery for those enrolled pre-operatively

    Voxel-based lesion-symptom mapping (VBLSM) correlating surgical lesion volumes in temporal lobe subregions (temporopolar, perirhinal, entorhinal, parahippocampal, hippocampal) with familiarity and recall behavioral scores.

  • ERP amplitude and latency associated with familiarity and recall (Aim II)During EEG recording session

    Amplitude and latency of event-related potential components (FN400, late positive component) in specified scalp regions (e.g., LAS, RAS, LPS, RPS) as a function of scene familiarity and recall conditions.

  • Intracranial theta and gamma power and connectivity during familiarity judgments (Aim III)During intracranial EEG monitoring (typically 1-2 weeks hospital stay)

    Theta (3-7 Hz) and gamma-band (30-150 Hz) event-related synchronization/desynchronization in parahippocampal, perirhinal, entorhinal, and hippocampal contacts during familiarity versus recall conditions, plus functional connectivity measures (imaginary coherence, phase-amplitude coupling).